Investors Careers FAQ Contact COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS Patent Portfolio Intellectual property protection and freedom to operate for ViaCyte and our partners ViaCyte’s patent portfolio includes hundreds of issued patents worldwide, and patent terms in the space extend for the next two decades or more. Patents have been issued in the United States and many countries around the world, including Australia, Belgium, Canada, China, Denmark, France, Germany, Hong Kong, Iceland, India, Ireland, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Poland, Republic of Korea, Russia, Singapore, South Africa, Spain, Sweden, Switzerland, and the United Kingdom. ViaCyte’s patent portfolio covers many of the intermediary cell types generated when human pluripotent stem cells progress along the differentiation pathway to pancreatic cells. ViaCyte has proprietary protocols for generating pancreatic progenitors and pancreatic endocrine cells at various stages of differentiation. ViaCyte’s intellectual property covers methods to manufacture and compositions of matter for: Culturing and expanding human pluripotent stem cells (e.g., human embryonic stem cells and induced pluripotent stem cells) and differentiating them to pancreatic progenitor and later stage endocrine precursor and endocrine cells including definitive endoderm, mesendoderm, and primitive foregut intermediate cell types Cell suspension and scale-up culture methods Pluripotent stem cell defined media Cyropreservation of pancreatic type cells Immune-evasive gene-edited pluripotent stem cells and cells derived from them Encapsulation of pancreatic cells Large-capacity cell encapsulation delivery device Directly vascularized delivery device Various tools and devices for the combination product including cell loading, packaging, and storage COMPANY TECHNOLOGIES PIPELINE NEWS & EVENTS CLINICAL TRIALS CONTACT Copyright 2021 ViaCyte, Inc. All Rights Reserved Terms of Service Privacy Policy We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT